Antibody molecules to PD-1 and uses thereof Grant US-11827704-B2 United States of America 28 Nov 2023
Compositions comprising an anti-LAG-3 antibody or an anti-LAG-3 antibody and an anti-PD-1… Grant US-11723975-B2 United States of America 15 Aug 2023
Combination of anti-LAG-3 antibodies and anti-PD-1 antibodies to treat tumors Grant US-11274152-B2 United States of America 15 Mar 2022
Method of detecting TIM-3 using antibody molecules to TIM-3 Grant US-11155620-B2 United States of America 26 Oct 2021
Antibody molecules to TIM-3 and uses thereof Grant US-10981990-B2 United States of America 20 Apr 2021
Compositions monovalent for CD28 binding and methods of use Grant US-10919965-B2 United States of America 16 Feb 2021
Antibody molecules to PD-1 and uses thereof Grant US-10752687-B2 United States of America 25 Aug 2020
Antibody molecules to TIM-3 and uses thereof Grant US-10472419-B2 United States of America 12 Nov 2019
Monoclonal antibodies to programmed death 1 (PD-1) Grant US-10441655-B2 United States of America 15 Oct 2019
Combination of anti-LAG-3 antibodies and anti-PD-1 antibodies to treat tumors Grant US-10081681-B2 United States of America 25 Sep 2018
Mammalian cell culture processes for protein production Grant US-10059754-B2 United States of America 28 Aug 2018
Mammalian cell culture processes for protein production Grant US-10030064-B2 United States of America 24 Jul 2018
Compositions monovalent for CD28 binding and methods of use Grant US-9908937-B2 United States of America 06 Mar 2018
Mammalian cell culture processes for protein production Grant US-9540426-B2 United States of America 10 Jan 2017
Monoclonal antibodies to Programmed Death 1 (PD-1) Grant US-9492539-B2 United States of America 15 Nov 2016
Methods for treating cancer using anti-PD-1 antibodies Grant US-9492540-B2 United States of America 15 Nov 2016
Monoclonal antibodies to programmed death 1 (PD-1) Grant US-9387247-B2 United States of America 12 Jul 2016
Methods for treating cancer using anti-PD-1 antibodies in combination with anti-CTLA-4… Grant US-9358289-B2 United States of America 07 Jun 2016
Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses Grant US-9181526-B2 United States of America 10 Nov 2015
Methods for treating cancer using anti-PD-1 antibodies Grant US-9084776-B2 United States of America 21 Jul 2015
Compositions monovalent for CD28 binding and methods of use Grant US-9085629-B2 United States of America 21 Jul 2015
Monoclonal antibodies to programmed death 1 (PD-1) Grant US-8779105-B2 United States of America 15 Jul 2014
Methods for treating Sjogrens syndrome by administering a soluble CTLA4 molecule Grant US-8722632-B2 United States of America 13 May 2014
Methods for treating juvenile rheumatoid arthritis by administering a soluble CTLA4… Grant US-8703718-B2 United States of America 22 Apr 2014
Methods for treating type I diabetes mellitus by administering a soluble CTLA4 molecule Grant US-8497247-B2 United States of America 30 Jul 2013
Compositions monovalent for CD28 binding and methods of use Grant US-8454959-B2 United States of America 04 Jun 2013
Method for treating an autoimmune disease using a soluble CTLA4 molecule and a DMARD or… Grant US-8227420-B2 United States of America 24 Jul 2012
Compositions monovalent for CD28 binding and methods of use Grant US-8168759-B2 United States of America 01 May 2012
Method for treating a rheumatic disease using a soluble TLA4 molecule Grant US-8148332-B2 United States of America 03 Apr 2012
Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses Grant US-8129185-B2 United States of America 06 Mar 2012
Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer… Application US-8008449-B2 United States of America 30 Aug 2011
Methods for downregulating CCR5 in T cells with anti-CD3 antibodies and anti-CD28… Grant US-7927595-B1 United States of America 19 Apr 2011
Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules Grant US-7829534-B2 United States of America 09 Nov 2010
Activation and expansion of T-cells using an engineered multivalent signaling platform as… Grant US-7745140-B2 United States of America 29 Jun 2010
Method of humanizing antibodies by matching canonical structure types CDRs Grant US-7709226-B2 United States of America 04 May 2010
Methods for treating cardiovascular disease using a soluble CTLA4 molecule Grant US-7671022-B2 United States of America 02 Mar 2010
Activation and expansion of T-cells using an agent that provides a primary activation… Grant US-7670781-B2 United States of America 02 Mar 2010
Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses Grant US-7651855-B2 United States of America 26 Jan 2010
Methods for treating immune system diseases using a soluble CTLA4 molecule Grant US-7455835-B2 United States of America 25 Nov 2008
Methods for treating cardiovascular disease using a soluble CTLA4 molecule Grant US-7307064-B2 United States of America 11 Dec 2007
Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules Grant US-7304033-B2 United States of America 04 Dec 2007
Methods for selectively stimulating proliferation of T cells Grant US-7144575-B2 United States of America 05 Dec 2006
Methods for blocking binding of CD28 receptor to B7 Grant US-7070776-B1 United States of America 04 Jul 2006
Methods for selectively stimulating proliferation of T cells Grant US-6905681-B1 United States of America 14 Jun 2005
Methods for selectively stimulating proliferation of T cells Grant US-6887466-B2 United States of America 03 May 2005
Method for generating and identifying antibodies directed against a B7 Grant US-6830937-B1 United States of America 14 Dec 2004
Methods of treating autoimmune disease via CTLA-4Ig Grant US-6685941-B1 United States of America 03 Feb 2004
Method of regulating cellular processes mediated by B7 and CD28 Grant US-6641809-B1 United States of America 04 Nov 2003
Methods for selectively stimulating proliferation of T cells Grant US-6534055-B1 United States of America 18 Mar 2003
Methods for inducing a population of T cells to proliferate using agents which recognize… Grant US-6352694-B1 United States of America 05 Mar 2002
Methods for selectively stimulating proliferation of T cells Grant US-5858358-A United States of America 12 Jan 1999